Innospec Inc. (NASDAQ:IOSP – Get Free Report) SVP Hardy Louis Griffin III sold 161 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $117.52, for a total value of $18,920.72. Following the completion of the sale, the senior vice president now owns 4,523 shares in the company, valued at $531,542.96. This represents a 3.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Innospec Stock Up 0.6 %
Innospec stock traded up $0.65 during trading hours on Thursday, hitting $115.61. 85,987 shares of the company traded hands, compared to its average volume of 107,984. Innospec Inc. has a 1-year low of $103.65 and a 1-year high of $133.71. The firm has a market cap of $2.88 billion, a P/E ratio of 20.18 and a beta of 1.09. The firm’s 50-day simple moving average is $113.50 and its two-hundred day simple moving average is $114.41.
Innospec (NASDAQ:IOSP – Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.35. The business had revenue of $443.40 million during the quarter, compared to analyst estimates of $442.13 million. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The firm’s revenue was down 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.59 earnings per share. On average, equities research analysts predict that Innospec Inc. will post 5.88 earnings per share for the current year.
Innospec Increases Dividend
Institutional Trading of Innospec
Hedge funds and other institutional investors have recently made changes to their positions in the business. Blue Trust Inc. increased its holdings in Innospec by 503.9% in the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock valued at $96,000 after purchasing an additional 650 shares during the last quarter. nVerses Capital LLC increased its stake in Innospec by 200.0% in the 3rd quarter. nVerses Capital LLC now owns 900 shares of the specialty chemicals company’s stock valued at $102,000 after buying an additional 600 shares during the last quarter. KBC Group NV boosted its position in Innospec by 82.3% during the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock valued at $136,000 after purchasing an additional 558 shares during the last quarter. Point72 Asset Management L.P. bought a new position in shares of Innospec in the third quarter valued at $215,000. Finally, Sanctuary Advisors LLC acquired a new position in shares of Innospec during the 2nd quarter worth about $233,000. 96.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of Innospec from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 11th.
Check Out Our Latest Analysis on Innospec
Innospec Company Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Articles
- Five stocks we like better than Innospec
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Following Congress Stock Trades
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.